Peer Review History

Original SubmissionNovember 11, 2022
Decision Letter - Hanna Landenmark, Editor

PONE-D-22-31111Health worker perspectives on access to antenatal care in rural plains Nepal during the pandemicPLOS ONE

Dear Dr. Morrison,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please see the reports from two reviewers below. Both reviewers have requested additional detail or clarification, particularly in the Methods section.

Please submit your revised manuscript by Apr 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Hanna Landenmark

Staff Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Overall, well written and well executed project.

I have these minor comments

As lines 61 - 128 are providing context on the situation in Nepal, I think it's best suited to be placed under "Setting" from line 131 as a "General Setting" subheading and then a subsequent "Specific Setting" subheading provided for the current information provided from line 132 - 161.

For Clarity; lines 200 to 202 can have "Ethical consideration" as a subheading

At the result section, the qualitative results and quantitative results are not immediately distinct. Including a table especially for the quantitative aspect of the study could help bring out clearly the outcomes of this aspect of your mixed method study.

Line 403 should be checked for clarity of thought and if needed broken into two sentences. Does "during, ..."relate to access to the phone or to ANC?

Reviewer #2: REVIEWERS COMMENTS

The study is objective is good. There are few comments however to be answered.

ABSTRACT

1.LINE 14-16: Not sure what you mean by health workers and community health volunteers. Aren’t community health volunteers part of health workers?

MATERIAL AND METHODS

SETTINGS

2.Are there health facilities in the district that provide above primary health care? Were they included in the study?

QUALITATIVE SAMPLING

3a. Line 164: How many health posts were in the district? Why did you opt for the 8 you used in the study?

3b. How were the interviews conducted? Direct or over the phone

QUANTITATIVE SAMPLING

4a.Line 188: How did you sample the 52 FCHVs for the study? What do you mean by 52 were available for study? Were the others under quarantine or they simply refused participation?

4b. Did you conduct direct interviews?

4c. line 200: Why verbal consent by some participants? Were they not accessible?

RESULTS

5. Line 325: I get the impression that tele medicine existed prior to the COVID-19 pandemic, didn’t you have the problem of lack of mobile phone access prevailing pre-pandemic? If it existed before the pandemic, how severe was it during the pandemic era?

LIMITATION

6. Line 413: the sentence should be looked at again. “Has” for ‘his’?

DISCUSSION

7. Line 387: I wish your quantitative data had covered other areas beyond IFA such as how many health posts lacked PPEs, how many PPEs were requested by each facility studied and how many were supplied. Without these facts, the statement on line 388 becomes questionable.

REFERENCES

8. Line 452: Not sure the journal which published the case study

9. Line 474: 2078? An error in the year?

10. Line 490: can you take a look again at the reference, 2064?

11. Line 585: the date for the publication

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer #1: Overall, well written and well executed project.

Response: Thank you for appreciating our paper and project.

I have these minor comments

As lines 61 - 128 are providing context on the situation in Nepal, I think it's best suited to be placed under "Setting" from line 131 as a "General Setting" subheading and then a subsequent "Specific Setting" subheading provided for the current information provided from line 132 - 161.

Response: We do not discuss the specific setting of the study in the introduction section, and headings mention the country context (Nepal). We have added to methods section heading we have added ‘study setting’ to clarify that this paragraph describes the specific context of the study.

For Clarity; lines 200 to 202 can have "Ethical consideration" as a subheading.

Response: We have added the subheading “Ethical consideration” to the mentioned lines as per your suggestion.

At the result section, the qualitative results and quantitative results are not immediately distinct. Including a table especially for the quantitative aspect of the study could help bring out clearly the outcomes of this aspect of your mixed method study.

Response: We have disaggregated our quantitative and qualitative sample in the methods section. Our quantitative data are not extensive, and therefore we feel they do not warrant a separate section.

Line 403 should be checked for clarity of thought and if needed broken into two sentences. Does "during, ..."relate to access to the phone or to ANC?

Response: Thank you for your suggestion. We have changed the line 403 to make it clearer.

Reviewer #2: REVIEWERS COMMENTS

The study is objective is good. There are few comments however to be answered.

ABSTRACT

1.LINE 14-16: Not sure what you mean by health workers and community health volunteers. Aren’t community health volunteers part of health workers?

Response: Thank you for your comment. Female Community Health Volunteers have no formal qualifications, and their role is mainly health promotion as described on page 4. They are a distinct cadre separate from health workers.

MATERIAL AND METHODS

SETTINGS

2.Are there health facilities in the district that provide above primary health care? Were they included in the study?

Response: There were hospitals providing higher levels of health care in the district headquarters. These were not included in this study because we chose to focus our research on primary health care only.

QUALITATIVE SAMPLING

3a. Line 164: How many health posts were in the district? Why did you opt for the 8 you used in the study?

Response: We sampled the eight health posts because we were already in contact with health workers from those health posts for another study (which has now been published and is referenced in the paper Saville et al. 2023). We have added the words ‘conveniently sampled’ to clarify that our sampling of health posts was convenient.

3b. How were the interviews conducted? Direct or over the phone

Response: The interviews were conducted directly, and we have added this detail to the paper on age 9.

QUANTITATIVE SAMPLING

4a.Line 188: How did you sample the 52 FCHVs for the study? What do you mean by 52 were available for study? Were the others under quarantine or they simply refused participation?

Response: There are a set number of FCHVs working under each health post. We sampled half the FCHVs working under the eight health posts. We have deleted the sentence about their availability as we agree with reviewers that it is confusing.

4b. Did you conduct direct interviews?

Response: Yes, we conducted direct interviews, and we have added this to the text.

4c. line 200: Why verbal consent by some participants? Were they not accessible?

Response: Some participants had low literacy and therefore we took verbal consent to participate from those participants. We have added to the text to clarify this.

RESULTS

5. Line 325: I get the impression that tele medicine existed prior to the COVID-19 pandemic, didn’t you have the problem of lack of mobile phone access prevailing pre-pandemic? If it existed before the pandemic, how severe was it during the pandemic era?

Response: FCHVs and health workers were meant to interact with pregnant women over the phone pre-pandemic. This was problematic before and during the pandemic because not all women had access to phones. Pre-pandemic FCHVs and health workers could interact face to face with women who didn’t have access to phones, but with lockdown preventing movement this was challenging. We have added to this paragraph on page 17 to clarify why lack of access was particularly troubling during the pandemic.

LIMITATION

6. Line 413: the sentence should be looked at again. “Has” for ‘his’?

Response: We have corrected this in our manuscript.

DISCUSSION

7. Line 387: I wish your quantitative data had covered other areas beyond IFA such as how many health posts lacked PPEs, how many PPEs were requested by each facility studied and how many were supplied. Without these facts, the statement on line 388 becomes questionable.

Response: We have removed the part about PPE in line 388.

REFERENCES

8. Line 452: Not sure the journal which published the case study

Response: Thank you for your comment. We have corrected the references for this case study.

9. Line 474: 2078? An error in the year?

10. Line 490: can you take a look again at the reference, 2064?

Response: The documents are published under the Nepali calendar, and the reference years are correct. If we changed the reference years, readers would not be able to find the references.

11. Line 585: the date for the publication

Response: We have added the date of publication.

Decision Letter - Seth Amponsah-Tabi, Editor

Health worker perspectives on access to antenatal care in rural plains Nepal during the COVID-19 pandemic

PONE-D-22-31111R1

Dear Dr. Morrison,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Seth Amponsah-Tabi

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Dear, the revised session is much better. I deem your responses to comments as appropriate.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Seth Amponsah-Tabi, Editor

PONE-D-22-31111R1

Health worker perspectives on access to antenatal care in rural plains Nepal during the COVID-19 pandemic

Dear Dr. Morrison:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Seth Amponsah-Tabi

Guest Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .